DiaSorin S.p.A. (OTCMKTS:DSRLF – Get Free Report) saw a large growth in short interest during the month of February. As of February 28th, there was short interest totalling 218,900 shares, a growth of 58.9% from the February 13th total of 137,800 shares. Based on an average trading volume of 100 shares, the short-interest ratio is currently 2,189.0 days. Approximately 0.4% of the company’s shares are sold short.
DiaSorin Price Performance
DiaSorin stock remained flat at $109.60 during trading on Friday. The company has a 50 day moving average price of $104.96 and a two-hundred day moving average price of $104.08. DiaSorin has a 1-year low of $100.26 and a 1-year high of $109.60.
Analyst Ratings Changes
Separately, UBS Group downgraded DiaSorin from a “strong-buy” rating to a “hold” rating in a report on Tuesday, November 26th.
DiaSorin Company Profile
DiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIASON IQ, LIAISON XL, LIAISON XXL, and LIAISON XL LAS.
Featured Stories
- Five stocks we like better than DiaSorin
- The 3 Best Blue-Chip Stocks to Buy Now
- How to Build the Ultimate Everything ETF Portfolio
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Dutch Bros or Starbucks: Which Coffee Stock Has More Growth?
- How to Invest in Biotech Stocks
- 3 Stocks With High ROE and Market-Beating Growth Potential
Receive News & Ratings for DiaSorin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DiaSorin and related companies with MarketBeat.com's FREE daily email newsletter.